The role of high-sensitivity C-reactive protein, interleukin-6 and cystatin C in ischemic stroke complicating atrial fibrillation

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 30, Issue 5, 2010, Pages 648-651

  You, Ling ^a   Wang, Peihua ^a   Lv, Jiagao ^a   Cianflone, Katherine ^b   Wang, Daowen ^a   Zhao, Chunxia ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

atrial fibrillation; C reactive protein; cystatin C; interleukin 6; ischemic stroke

Indexed keywords

C REACTIVE PROTEIN; CYSTATIN C; INTERLEUKIN 6;

AGED; ARTICLE; BLOOD; BRAIN ISCHEMIA; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; RISK FACTOR;

AGED; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CYSTATIN C; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STROKE;

EID: 78649828229     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-010-0558-6     Document Type: Article

References (24)

1. A.S. Go E.M. Hylek K.A. Phillips, et al. 2001 Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study JAMA 285 18 2370 2375 1:STN:280:DC%2BD3M3ntleitQ%3D%3D 10.1001/jama.285.18.2370 11343485
2. C.D. Furberg B.M. Psaty T.A. Manolio, et al. 1994 Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study) Am J Cardiol 74 3 236 241 1:STN:280:DyaK2czhtFaiuw%3D%3D 10.1016/0002-9149(94)90363-8 8037127 (Pubitemid 24239044)
3. No authors listed. 1994 Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials Arch Intern Med 154 19 1449 1457
4. P.A. Wolf R.D. Abbott W.B. Kannel 1991 Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 8 983 988 1:STN:280:DyaK3Mzislektg%3D%3D 1866765
5. R.G. Hart J.L. Halperin 1999 Atrial Fibrillation and thromboembolism: A decade of progress in stroke prevention Ann Intern Med 131 9 688 695 1:STN:280:DyaK1Mvls1CmsA%3D%3D 10577332
6. C.J. Boos R.A. Anderson G.Y. Lip 2006 Is atrial fibrillation an inflammatory disorder? Eur Heart J 27 2 136 149 10.1093/eurheartj/ehi645 16278230 (Pubitemid 43069029)
7. V. Roldán F. Marín J.G. Martínez, et al. 2005 Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation Am J Cardiol 95 7 881 882 10.1016/j.amjcard.2004.12.016 15781023 (Pubitemid 40386805)
8. R.H. Abdelhadi H.S. Gurm D.R. Van Wagoner, et al. 2004 Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively Am J Cardiol 93 9 1176 8 10.1016/j.amjcard.2004.01.053 15110218 (Pubitemid 38521055)
9. M.G. Shlipak M.J. Sarnak R. Katz, et al. 2005 Cystatin C and the risk of death and cardiovascular events among elderly persons N Engl J Med 352 20 2049 2060 1:CAS:528:DC%2BD2MXkt1Klsbk%3D 10.1056/NEJMoa043161 15901858 (Pubitemid 40664306)
10. S.N. Psychari T.S. Apostolou L. Sinos, et al. 2005 Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation Am J Cardiol 95 6 764 767 1:CAS:528:DC%2BD2MXitFCitr4%3D 10.1016/j.amjcard.2004.11.032 15757607 (Pubitemid 40340139)
11. M.K. Chung D.O. Martin D. Sprecher, et al. 2001 C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation Circulation 104 24 2886 2891 1:CAS:528:DC%2BD38XjvVKisw%3D%3D 10.1161/hc4901.101760 11739301
12. R.J. Aviles D.O. Martin C. Apperson-Hansen, et al. 2003 Inflammation as a risk factor for atrial fibrillation Circulation 108 24 3006 3010 10.1161/01.CIR.0000103131.70301.4F 14623805 (Pubitemid 37553570)
13. D.S. Conway P. Buggins E. Hughes, et al. 2004 Relation of interleukin-6, C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation Am J Cardiol 93 11 1368 1373 1:CAS:528:DC%2BD2cXksVGgsrY%3D 10.1016/j.amjcard.2004.02.032 15165916 (Pubitemid 38692463)
14. D.S. Conway P. Buggins E. Hughes, et al. 2004 Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation J Am Coll Cardiol 43 11 2075 2082 1:CAS:528: DC%2BD2cXksVCjtL0%3D 10.1016/j.jacc.2003.11.062 15172416 (Pubitemid 38686805)
15. The SPAF III writing committee for the stroke prevention in atrial fibrillation investigators. 1998 Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke prevention in atrial fibrillation III study JAMA 279 16 1273 1277 10.1001/jama.279.16.1273 (Pubitemid 28180779)
16. E.J. Benjamin D. Levy S.M. Vaziri, et al. 1994 Independent risk factors for atrial fibrillation in a population-based cohort The Framingham Heart Study. JAMA 271 11 840 844 1:STN:280:DyaK2c7lvVSksg%3D%3D
17. D.G. Sherman L. Goldman R.B. Whiting, et al. 1984 Thromboembolism in patients with atrial fibrillation Arch Neurol 41 7 708 710 1:STN:280: DyaL2c3ls1Wgtw%3D%3D 6743058
18. The stroke prevention in atrial fibrillation investigators. 1992 Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk Ann Intern Med 116 1 1 5
19. J.P. Kistler D.E. Singer M.M. Millenson, et al. 1993 Effect of low-intensity warfarin anticoagulation on level of activity of the hemostatic system in patients with atrial fibrillation BAATAF Investigators. Stroke 24 9 1360 1365 1:STN:280:DyaK3szmvFymtw%3D%3D
20. J.E. Fonseca M.J. Santos H. Canhão, et al. 2009 Interleukin-6 as a key player in systemic inflammation and joint destruction Autoimmun Rev 8 7 538 542 1:CAS:528:DC%2BD1MXovFaqs70%3D 10.1016/j.autrev.2009.01.012 19189867
21. H. Yamagami K. Kitagawa Y. Nagai, et al. 2004 Higher levels of interleukin-6 are associated with lower echogenicity of carotid artery plaques Stroke 35 3 677 681 1:CAS:528:DC%2BD2cXhsFeisLo%3D 10.1161/01.STR.0000116876. 96334.82 14752126 (Pubitemid 38280840)
22. G. Filler A. Bökenkamp W. Hofmann, et al. 2005 Cystatin C as a marker of GFR-history, indications, and future research Clin Biochem 38 1 1 8 1:CAS:528:DC%2BD2cXhtVyqsLbN 10.1016/j.clinbiochem.2004.09.025 15607309 (Pubitemid 39647648)
23. C. Briguori G. Visconti N.V. Rivera, et al. 2010 Cystatin C and contrast-induced acute kidney injury Circulation 121 19 2117 2122 1:CAS:528:DC%2BC3cXmtFOis7Y%3D 10.1161/CIRCULATIONAHA.109.919639 20439784
24. L. Ni J. Lü L.B. Hou, et al. 2007 Cystatin C, associated with hemorrhagic and ischemic stroke, is a strong predictor of the risk of cardiovascular events and death in Chinese Stroke 38 12 3287 3288 1:CAS:528:DC%2BD2sXhtlSlt7bF 10.1161/STROKEAHA.107.489625 17947596 (Pubitemid 350175750)